Holy Hormones Journal: Oh, dear. Scientists have found a link between post-menopausal hormone treatment therapy and meningioma. HRT can escalate the risk of getting a brain tumor by 30 percent. Not only that women on hormone replacement therapy for more than 10 years had a 70% chance of developing brain tumors. Synthetic hormones are steriods Continue Reading …
Holy Hormones Journal: It seems that every few years Hormone Replacement Therapy – HRT – raises its ugly head – even though hundreds of lawsuits have been filed linking HRT to breast cancer. Just because the two organizations below are ‘women’s organizations’ methinks there is some Pharma money lurking behind their endorsing new HRT guidelines. Continue Reading …
The Society for Women’s Health Research (SWHR) revealed today in The Journal of Women’s Health, the results of their expert, international roundtable on Menopausal Hormone Therapy (HT), illuminating the controversies and misrepresentations that have impeded women’s abilities to make choices about their own healthcare.
Using a 200-year-old data set of more than 14,000 people, researchers found that the need for older child-free women in human societies and reproductive conflict between in-laws may account for menopause in human females.
Observational studies suggest reduced risk of Alzheimer disease (AD) in users of hormone therapy (HT), but trials show higher risk. We examined whether the association of HT with AD varies with timing or type of HT use.
In the 10 years since hormone treatment was deemed too risky, many more women have chosen to endure symptoms of aging rather than take the “other pill.” Yet, more than half remain confused about the risks and benefits.
The attorney said Fraser began taking Prempro in the mid-1990s, when she was about 50 years old. Her gynecologist prescribed it after Fraser began experiencing hot flashes. Fraser, according to court documents, testified that she continued taking the drug because “it was working… and because my doctor felt it was safe.” Advertisements for the drug at that time also “enhanced” her decision to keep taking it.
According to a study published March 15 in the Journal of the National Cancer Institute, thoughts about how estrogen alone or estrogen in addition to progestin influence the risk of developing breast cancer has considerably changed in the past 10 years due to results from the Women’s Health Initiative (WHI) randomized placebo-controlled hormone therapy trials, and from large prospective cohort studies.